Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Serotonin Syndrome × Random Allocation × Endocrine × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Serotonin Syndrome 1 Neuroendocrine Tumors 1 Carcinoid Tumors, Intestinal 1 Carcinoid Tumor 1

Interventions

telotristat ethyl 3 lanreotide 2 pasireotide 1 lutetium Lu 177 dotatate 1 Receptor-Like Protein Tyrosine Phosphatases, Class 2 1 Random Allocation 1 Panitumumab 1 Octreotide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05361668 2025-10-31

Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome

Crinetics Pharmaceuticals Inc.

Phase 2 Active not recruiting

36 enrolled 19 charts

Carcinoid Tumors, Intestinal, Carcinoid Tumor, Neuroendocrine Tumors, Serotonin Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡